Anti-metastasis therapy: Curcumin, the major componet of turmeric, inhibits invasive motility via down regulation of ICAT (Inhibitor of β-catenin and TCF), 20/October/2014, 16.06

Anti-metastasis therapy: Curcumin, the major componet of turmeric, inhibits invasive motility via down regulation of ICAT (Inhibitor of β-catenin and TCF), 20/October/2014, 16.06

Anti-metastasis therapy: Curcumin, the major componet of turmeric, inhibits invasive motility via down regulation of ICAT (Inhibitor of β-catenin and TCF), 20/October/2014, 16.06 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

CitationBoominathan, L., Anti-metastasis therapy: Curcumin, the major componet of turmeric, inhibits invasive motility via down regulation of ICAT (Inhibitor of β-catenin and TCF), 20/October/2014, 16.08, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that Curcumin, by increasing the expression of its target gene, it may decrease the expression of EMT protein ICAT.  Therefore, pharmacological formulations encompassing Curcumin or its analogues may be used to treat metastatic cancers.

* Research cooperation